Health Insurance CEO’s Killing Sparks Outrage and Exposes Frustration with U.S. Healthcare System

The “brazen and targeted” killing of Brian Thompson, CEO of UnitedHealthcare, outside a New York hotel, has shocked the nation. Thompson’s death has not only drawn attention to the tragic incident itself but has also ignited a wave of public anger toward the trillion-dollar health insurance industry. The murder has amplified ongoing frustrations with a system that many Americans believe is broken.

The phrase “prior authorisation,” central to insurance operations, has become a flashpoint of contention. This process allows insurers to evaluate and approve medical treatments before agreeing to cover them. Critics argue that such measures often lead to delays or outright denials of necessary care.

This sentiment was palpable during a July protest outside UnitedHealthcare’s Minnesota headquarters. Over 100 people from various states, including Maine, Texas, and West Virginia, gathered to decry the company’s policies and denial of claims. The demonstration, organised by the People’s Action Institute, resulted in the arrest of eleven protesters for blocking a road. According to Unai Montes-Irueste, the group’s media strategy director, many of those present had personal experiences with claim denials. “They are denied care, then they have to go through an appeals process that’s incredibly difficult to win,” Montes-Irueste explained.

This underlying frustration burst into the spotlight following Thompson’s murder. As the CEO of UnitedHealthcare, the insurance division of UnitedHealth Group, Thompson led the largest insurer in the U.S. While police are still searching for the suspect and the motive remains unclear, shell casings found at the crime scene bore words like “deny,” “defend,” and “depose”—terms critics associate with tactics insurers allegedly use to avoid payouts.

Online reactions to Thompson’s death revealed the deep-seated anger many feel toward the health insurance industry. A scan of Thompson’s LinkedIn profile showed comments from individuals frustrated with denied claims. One woman with stage 4 metastatic lung cancer wrote, “We’ve just left [UnitedHealthcare] because of all the denials for my meds. Every month there is a different reason for the denial.”

Thompson’s wife, Paulette Thompson, shared that he had received threats before the incident. “There had been some threats,” she told NBC. “Basically, I don’t know, a lack of [medical] coverage? I don’t know details. I just know that he said there were some people that had been threatening him.”

Philip Klein, a security expert who previously worked with Thompson, expressed shock over the lack of security during the executive’s New York trip. “There’s a lot of anger in the United States of America right now,” he remarked. Klein noted that corporate leaders often face threats stemming from public frustration over high costs and limited access. “Companies need to wake up and realise that their executives could be hunted down anywhere,” he added.

Following the shooting, politicians and industry officials expressed condolences. Michael Tuffin, president of the insurance industry organisation Ahip, called Thompson’s death a tragedy. “He was a devoted father, a good friend to many, and a refreshingly candid colleague and leader,” Tuffin said. UnitedHealth Group acknowledged the support it had received from “patients, consumers, health care professionals, associations, government officials, and other caring people.”

However, online commentary painted a contrasting picture. Many criticized insurance companies for claim denials and excessive costs. Some used dark humor, such as quipping “thoughts and prior authorisations,” a play on the common phrase “thoughts and prayers.” Others went as far as celebrating Thompson’s death, reflecting the depth of animosity toward the system. The outrage spanned the political spectrum, uniting left-wing activists, right-wing critics of corporate influence, and ordinary individuals sharing personal stories of denied care.

Montes-Irueste, while condemning the violence, acknowledged the widespread bitterness. “We have a balkanised and broken healthcare system,” he said, adding that the frustration stems from diverse experiences with a system that many feel is failing them.

Criticism of the insurance industry is not new. A recent Commonwealth Fund study revealed that 45% of insured working-age adults were billed for services they believed should have been covered. Additionally, 17% reported that their insurers denied coverage for doctor-recommended care. Less than half of those who suspected billing errors chose to contest them, highlighting the complexity and opacity of the system.

Sara Collins, a senior scholar at The Commonwealth Fund, described the U.S. healthcare system as both expensive and convoluted. “Just navigating and understanding how you get covered can be challenging for people,” she explained. While things might appear manageable when people are healthy, problems often arise when they require substantial medical care. Collins added, “We find high rates of people saying that their healthcare costs are unaffordable, across all insurance types, even Medicaid and Medicare. We truly have a medical debt crisis.”

The high costs of healthcare in the U.S. exacerbate these issues. Christine Eibner, a senior economist at the RAND Corporation, noted that average insurance premiums for a family hover around $25,000 annually, with out-of-pocket expenses often adding thousands more. “On top of that, people face out-of-pocket costs, which could easily be in the thousands of dollars,” she said.

UnitedHealthcare and other major insurers have faced lawsuits and investigations over their practices. Last year, UnitedHealthcare settled a case involving a chronically ill college student who amassed $800,000 in medical debt after his prescribed medications were denied. ProPublica, which covered the case, highlighted how the student struggled under the weight of the bills. The company is also contesting a class-action lawsuit accusing it of using artificial intelligence to prematurely terminate treatments.

Despite these controversies, many Americans still hold favorable views of their insurers. A survey by KFF found that while two-thirds blamed insurance companies for high healthcare costs, 81% rated their coverage as “excellent” or “good.”

Yet, the anger remains palpable, reflecting a broader dissatisfaction with a system that leaves many feeling vulnerable and neglected. As Tuffin defended the industry, calling his colleagues “mission-driven professionals working to make coverage and care as affordable as possible,” the divide between public perception and industry claims became starkly evident.

For now, the murder of Brian Thompson serves as a grim reminder of the tensions that exist within the U.S. healthcare system. Whether it leads to meaningful reforms or further entrenches the divide between insurers and the public remains to be seen.